{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:10:20Z","timestamp":1781197820266,"version":"3.54.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05803-9","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:31:20Z","timestamp":1739291480000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Headache as the most common manifestation of giant cell arteritis?: a systematic review with meta-analysis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-4197-1115","authenticated-orcid":false,"given":"Aleksander","family":"Osiowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7533-2691","authenticated-orcid":false,"given":"Maksymilian","family":"Osiowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2648-5851","authenticated-orcid":false,"given":"Kacper","family":"Stolarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4806-2094","authenticated-orcid":false,"given":"Tomasz","family":"Klepinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5135-6750","authenticated-orcid":false,"given":"Dominik","family":"Taterra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"5803_CR1","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/rheumatology\/kew273","volume":"56","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F et al (2017) The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford) 56:506\u2013515. https:\/\/doi.org\/10.1093\/rheumatology\/kew273","journal-title":"Rheumatology (Oxford)"},{"key":"5803_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"CM Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349:160\u2013169. https:\/\/doi.org\/10.1056\/NEJMra022694","journal-title":"N Engl J Med"},{"key":"5803_CR3","doi-asserted-by":"publisher","unstructured":"Elfishawi MM, Kaymakci MS, Achenbach SJ et al (2023) Reappraisal of large artery involvement in giant cell arteritis: a population-based cohort over 70 years. RMD Open; 10. https:\/\/doi.org\/10.1136\/rmdopen-2023-003775","DOI":"10.1136\/rmdopen-2023-003775"},{"key":"5803_CR4","first-page":"48","volume":"23","author":"AD Meshkov","year":"2014","unstructured":"Meshkov AD, Novikov PI, Fomin VV, Moiseev SV (2014) Giant cell arteritis: diagnostic and treatment. Klin Farmakol Ter 23:48\u201354","journal-title":"Klin Farmakol Ter"},{"key":"5803_CR5","doi-asserted-by":"publisher","unstructured":"Satybaldyev AM (2012) \u0413\u0438\u0433\u0430\u043d\u0442\u043e\u043a\u043b\u0435\u0442\u043e\u0447\u043d\u044b\u0439 \u0430\u0440\u0442\u0435\u0440\u0438\u0438\u0442. \u0427\u0430\u0441\u0442\u044c I. \u0422\u0435\u0440\u043c\u0438\u043d\u043e\u043b\u043e\u0433\u0438\u044f, \u043a\u043b\u0430\u0441\u0441\u0438\u0444\u0438\u043a\u0430\u0446\u0438\u044f, \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043f\u0440\u043e\u044f\u0432\u043b\u0435\u043d\u0438\u044f, \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430. \u0421\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u0430\u044f \u0440\u0435\u0432\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f; 6: 23\u201327. https:\/\/doi.org\/10.14412\/1996-7012-2012-741","DOI":"10.14412\/1996-7012-2012-741"},{"key":"5803_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2014.01.017","volume":"48\u201349","author":"G Nesher","year":"2014","unstructured":"Nesher G (2014) The diagnosis and classification of giant cell arteritis. J Autoimmun 48\u201349:73\u201375. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.017","journal-title":"J Autoimmun"},{"key":"5803_CR7","doi-asserted-by":"publisher","DOI":"10.1134\/S1607672924700984","author":"EE Fedorinova","year":"2024","unstructured":"Fedorinova EE, Bulanov NM, Meshkov AD et al (2024) Clinical manifestations and prognosis of giant cell arteritis: a retrospective cohort study. Dokl Biochem Biophys. https:\/\/doi.org\/10.1134\/S1607672924700984","journal-title":"Dokl Biochem Biophys"},{"key":"5803_CR8","first-page":"1484","volume":"21","author":"RD Wigley","year":"1994","unstructured":"Wigley RD (1994) Rheumatic diseases in China: ILAR-China study comparing the prevalence of rheumatic symptoms in northern and southern rural populations. J Rheumatol 21:1484\u20131490","journal-title":"J Rheumatol"},{"key":"5803_CR9","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/art.1780261007","volume":"26","author":"CA Smith","year":"1983","unstructured":"Smith CA, Fidler WJ, Pinals RS (1983) The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 26:1214\u20131219. https:\/\/doi.org\/10.1002\/art.1780261007","journal-title":"Arthritis Rheum"},{"key":"5803_CR10","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/art.11195","volume":"49","author":"S Kobayashi","year":"2003","unstructured":"Kobayashi S, Yano T, Matsumoto Y et al (2003) Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 49:594\u2013598. https:\/\/doi.org\/10.1002\/art.11195","journal-title":"Arthritis Rheum"},{"key":"5803_CR11","doi-asserted-by":"publisher","unstructured":"Olesen J (2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia; 38: 1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","DOI":"10.1177\/0333102417738202"},{"key":"5803_CR12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8","volume":"41","author":"MA Gonz\u00e1lez-Gay","year":"1998","unstructured":"Gonz\u00e1lez-Gay MA (1998) Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum 41:1497\u20131504. https:\/\/doi.org\/10.1002\/1529-0131(199808)41:8","journal-title":"Arthritis Rheum"},{"key":"5803_CR13","first-page":"2166","volume":"24","author":"MA Gonz\u00e1lez-Gay","year":"1997","unstructured":"Gonz\u00e1lez-Gay MA, Blanco R, S\u00e1nchez-Andrade A et al (1997) Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features. J Rheumatol 24:2166\u20132170","journal-title":"J Rheumatol"},{"key":"5803_CR14","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Lozano D, Hern\u00e1ndez-Rodr\u00edguez I, Narvaez J et al (2023) Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register. RMD Open 10. https:\/\/doi.org\/10.1136\/rmdopen-2023-003824","DOI":"10.1136\/rmdopen-2023-003824"},{"key":"5803_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/ard.58.6.335","volume":"58","author":"P Duhaut","year":"1999","unstructured":"Duhaut P, Pin\u00e8de L, Bornet H et al (1999) Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Groupe De Recherche sur l\u2019Art\u00e9rite \u00e0 Cellules G\u00e9antes. Ann Rheum Dis 58:335\u2013341. https:\/\/doi.org\/10.1136\/ard.58.6.335","journal-title":"Ann Rheum Dis"},{"key":"5803_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3899\/jrheum.161033","volume":"44","author":"H De Boysson","year":"2017","unstructured":"De Boysson H, Liozon E, Larivi\u00e8re D et al (2017) Giant cell arteritis-related stroke: a retrospective multicenter case-control study. J Rheumatol 44:297\u2013303. https:\/\/doi.org\/10.3899\/jrheum.161033","journal-title":"J Rheumatol"},{"key":"5803_CR17","doi-asserted-by":"publisher","unstructured":"Castillejo Becerra CM, Crowson CS, Koster MJ et al (2022) Population-based Rate and Patterns of Diplopia in Giant Cell Arteritis. Neuroophthalmology; 46: 75\u201379. https:\/\/doi.org\/10.1080\/01658107.2021.1965627","DOI":"10.1080\/01658107.2021.1965627"},{"key":"5803_CR18","doi-asserted-by":"publisher","first-page":"816","DOI":"10.55563\/clinexprheumatol\/zr7s0g","volume":"42","author":"F Alibaz-\u00d6ner","year":"2024","unstructured":"Alibaz-\u00d6ner F, Kelesoglu B, Balci MA et al (2024) Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry. Clin Exp Rheumatol 42:816\u2013821. https:\/\/doi.org\/10.55563\/clinexprheumatol\/zr7s0g","journal-title":"Clin Exp Rheumatol"},{"key":"5803_CR19","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","volume":"81","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC et al (2022) American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 81:1647\u20131653. https:\/\/doi.org\/10.1136\/ard-2022-223480","journal-title":"Ann Rheum Dis"},{"key":"5803_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1093\/rheumatology\/kew397","volume":"56","author":"M Yates","year":"2017","unstructured":"Yates M, MacGregor AJ, Robson J et al (2017) The association of vascular risk factors with visual loss in giant cell arteritis. Rheumatology (Oxford) 56:524\u2013528. https:\/\/doi.org\/10.1093\/rheumatology\/kew397","journal-title":"Rheumatology (Oxford)"},{"key":"5803_CR21","doi-asserted-by":"crossref","unstructured":"Chase E, Patel BC, Ramsey ML (2023) Temporal Artery Biopsy. Fundamentals of Ophthalmic Practice: a Guide for Medical Students, Ophthalmology Trainees, Nurses, Orthoptists and Optometrists; 171\u2013176","DOI":"10.1142\/9789811270642_0022"},{"key":"5803_CR22","doi-asserted-by":"publisher","unstructured":"Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA; 283: 2008\u20132012. https:\/\/doi.org\/10.1001\/jama.283.15.2008","DOI":"10.1001\/jama.283.15.2008"},{"key":"5803_CR23","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ; 372. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"5803_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122\u20131128. https:\/\/doi.org\/10.1002\/art.1780330810","journal-title":"Arthritis Rheum"},{"key":"5803_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/001316446002000104","volume":"20","author":"J Cohen","year":"1960","unstructured":"Cohen J (1960) A coefficient of Agreement for Nominal scales. Educ Psychol Meas 20:37\u201346. https:\/\/doi.org\/10.1177\/001316446002000104","journal-title":"Educ Psychol Meas"},{"key":"5803_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/xeb.0000000000000054","volume":"13","author":"Z Munn","year":"2015","unstructured":"Munn Z, MClinSc SM, Lisy K et al (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid Based Healthc 13:147\u2013153. https:\/\/doi.org\/10.1097\/xeb.0000000000000054","journal-title":"Int J Evid Based Healthc"},{"key":"5803_CR27","unstructured":"Naing L, Winn T, Nordin R (2006) Practical issues in calculating the sample size for Prevalence studies. Medical statistics. Archives Orofac Sci; 9\u201314"},{"key":"5803_CR28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.ajodo.2019.12.011","volume":"157","author":"LM Spineli","year":"2020","unstructured":"Spineli LM, Pandis N (2020) Prediction interval in random-effects meta-analysis. Am J Orthod Dentofac Orthop 157:586\u2013588. https:\/\/doi.org\/10.1016\/j.ajodo.2019.12.011","journal-title":"Am J Orthod Dentofac Orthop"},{"key":"5803_CR29","doi-asserted-by":"publisher","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","volume":"6","author":"J IntHout","year":"2016","unstructured":"IntHout J, Ioannidis JPA, Rovers MM et al (2016) Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open 6:e010247. https:\/\/doi.org\/10.1136\/bmjopen-2015-010247","journal-title":"BMJ Open"},{"key":"5803_CR30","doi-asserted-by":"crossref","unstructured":"Higgins JP (2008) Cochrane Handbook for systematic reviews of interventions: Cochrane Book Series. Cochrane Book Ser; 1\u2013649","DOI":"10.1002\/9780470712184"},{"key":"5803_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/xeb.0000000000000141","volume":"16","author":"L Furuya-Kanamori","year":"2018","unstructured":"Furuya-Kanamori L, Barendregt JJ, Doi SAR (2018) A new improved graphical and quantitative method for detecting bias in meta-analysis. Int J Evid Based Healthc 16:195\u2013203. https:\/\/doi.org\/10.1097\/xeb.0000000000000141","journal-title":"Int J Evid Based Healthc"},{"key":"5803_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/rhu.0b013e31823e2e35","volume":"18","author":"MA Alba","year":"2012","unstructured":"Alba MA, Mena-Madrazo JA, Reyes E et al (2012) Giant cell arteritis in Mexican patients. J Clin Rheumatol 18:1\u20137. https:\/\/doi.org\/10.1097\/rhu.0b013e31823e2e35","journal-title":"J Clin Rheumatol"},{"key":"5803_CR33","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00296-024-05540-5","volume":"44","author":"F Alnaimat","year":"2024","unstructured":"Alnaimat F, Alduradi H, Al-Qasem S et al (2024) Giant cell arteritis: insights from a monocentric retrospective cohort study. Rheumatol Int 44:1013\u20131023. https:\/\/doi.org\/10.1007\/s00296-024-05540-5","journal-title":"Rheumatol Int"},{"key":"5803_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.reumae.2024.04.003","volume":"20","author":"I del Blanco Alonso","year":"2024","unstructured":"del Blanco Alonso I, Revilla Calavia \u00c1, Saiz-Viloria L et al (2024) Cost-effectiveness analysis of the diagnosis of temporal arteritis. Reumatol Clin 20:181\u2013186. https:\/\/doi.org\/10.1016\/j.reumae.2024.04.003","journal-title":"Reumatol Clin"},{"key":"5803_CR35","doi-asserted-by":"publisher","unstructured":"Andel PM, Diamantopoulos AP, Myklebust G et al (2022) Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR\/EULAR classification criteria. Front Med (Lausanne) 10. https:\/\/doi.org\/10.3389\/fmed.2023.1286601","DOI":"10.3389\/fmed.2023.1286601"},{"key":"5803_CR36","first-page":"734","volume":"105","author":"J Armona","year":"1995","unstructured":"Armona J, Rodriguez-Valverde V, Gonzalez-Gay MA et al (1995) ARTERITIS DE CELULAS GIGANTES. ESTUDIO DE 191 PACIENTES. Med Clin (Barc) 105:734\u2013737","journal-title":"Med Clin (Barc)"},{"key":"5803_CR37","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1007\/s10067-021-05643-5","volume":"40","author":"H Baalbaki","year":"2021","unstructured":"Baalbaki H, Jalaledin D, Lachance C et al (2021) Characterization of visual manifestations and identification of risk factors for permanent vision loss in patients with giant cell arteritis. Clin Rheumatol 40:3207\u20133217. https:\/\/doi.org\/10.1007\/s10067-021-05643-5","journal-title":"Clin Rheumatol"},{"key":"5803_CR38","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/art.1780370705","volume":"37","author":"\u00d3 Baldursson","year":"1994","unstructured":"Baldursson \u00d3, Steinsson K, Bj\u00f6rnsson J et al (1994) Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 37:1007\u20131012. https:\/\/doi.org\/10.1002\/art.1780370705","journal-title":"Arthritis Rheum"},{"key":"5803_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/rheumatology\/ken480","volume":"48","author":"CT Berger","year":"2009","unstructured":"Berger CT, Wolbers M, Meyer P et al (2009) High incidence of severe ischaemic complications in patients with giant cell arteritis irrespective of platelet count and size, and platelet inhibition. Rheumatology (Oxford) 48:258\u2013261. https:\/\/doi.org\/10.1093\/rheumatology\/ken480","journal-title":"Rheumatology (Oxford)"},{"key":"5803_CR40","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s10067-018-4068-4","volume":"37","author":"G Bornstein","year":"2018","unstructured":"Bornstein G, Barshack I, Koren-Morag N et al (2018) Negative temporal artery biopsy: predictive factors for giant cell arteritis diagnosis and alternate diagnoses of patients without arteritis. Clin Rheumatol 37:2819\u20132824. https:\/\/doi.org\/10.1007\/s10067-018-4068-4","journal-title":"Clin Rheumatol"},{"key":"5803_CR41","first-page":"1103","volume":"26","author":"GS Breuer","year":"2008","unstructured":"Breuer GS, Nesher R, Nesher G (2008) Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis. Clin Exp Rheumatol 26:1103\u20131106","journal-title":"Clin Exp Rheumatol"},{"key":"5803_CR42","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/art.23700","volume":"58","author":"D Chatelain","year":"2008","unstructured":"Chatelain D, Duhaut P, Loire R et al (2008) Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica? Arthritis Rheum 58:2565\u20132573. https:\/\/doi.org\/10.1002\/art.23700","journal-title":"Arthritis Rheum"},{"key":"5803_CR43","doi-asserted-by":"publisher","unstructured":"Chehem Daoud Chehem F, de Mornac D, Feuillet F et al (2023) Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study. Semin Arthritis Rheum; 64. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152348","DOI":"10.1016\/j.semarthrit.2023.152348"},{"key":"5803_CR44","doi-asserted-by":"publisher","unstructured":"Chu X, Wang D, Zhang Y et al (2019) Comparisons of clinical manifestations and prognosis between giant cell arteritis patients with or without sensorineural hearing loss: a retrospective study of Chinese patients. Medicine 98. https:\/\/doi.org\/10.1097\/md.0000000000015286","DOI":"10.1097\/md.0000000000015286"},{"key":"5803_CR45","first-page":"83","volume":"6","author":"RM Cunha","year":"1993","unstructured":"Cunha RM (1993) ARTERITE DE C\u00c9LULAS GIGANTES (DOEN\u00c7A DE HORTON): a Prop\u00f3sito De 18 Casos. Acta Med Port 6:83\u201385","journal-title":"Acta Med Port"},{"key":"5803_CR46","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/art.41527","volume":"73","author":"L Delaval","year":"2021","unstructured":"Delaval L, Samson M, Schein F et al (2021) Temporal arteritis revealing Antineutrophil cytoplasmic antibody-Associated vasculitides: a case-control study. Arthritis Rheumatol 73:286\u2013294. https:\/\/doi.org\/10.1002\/art.41527","journal-title":"Arthritis Rheumatol"},{"key":"5803_CR47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/imj.12293","volume":"44","author":"E Dunstan","year":"2014","unstructured":"Dunstan E, Lester SL, Rischmueller M et al (2014) Epidemiology of biopsy-proven giant cell arteritis in South Australia. Intern Med J 44:32\u201339. https:\/\/doi.org\/10.1111\/imj.12293","journal-title":"Intern Med J"},{"key":"5803_CR48","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1007\/s13760-020-01344-z","volume":"120","author":"AM Elhfnawy","year":"2020","unstructured":"Elhfnawy AM, Elsalamawy D, Abdelraouf M et al (2020) Red flags for a concomitant giant cell arteritis in patients with vertebrobasilar stroke: a cross-sectional study and systematic review. Acta Neurol Belg 120:1389\u20131398. https:\/\/doi.org\/10.1007\/s13760-020-01344-z","journal-title":"Acta Neurol Belg"},{"key":"5803_CR49","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3899\/jrheum.140562","volume":"42","author":"S Furuta","year":"2015","unstructured":"Furuta S, Cousins C, Chaudhry A et al (2015) Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J Rheumatol 42:300\u2013308. https:\/\/doi.org\/10.3899\/jrheum.140562","journal-title":"J Rheumatol"},{"key":"5803_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.revmed.2023.12.005","volume":"45","author":"N Lomba Goncalves","year":"2024","unstructured":"Lomba Goncalves N, Tran VT, Chauffier J et al (2024) [Clinical characteristics and follow-up of 60 patients with recent diagnosis of giant cell arteritis, NEWTON study]. Rev Med Interne 45:335\u2013342. https:\/\/doi.org\/10.1016\/j.revmed.2023.12.005","journal-title":"Rev Med Interne"},{"issue":"5","key":"5803_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/01.md.0000180043.19285.54","volume":"84","author":"MA Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S et al (2005) Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine 84(5):277\u2013290. https:\/\/doi.org\/10.1097\/01.md.0000180043.19285.54","journal-title":"Medicine"},{"key":"5803_CR52","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","volume":"84","author":"MA Gonzalez-Gay","year":"2005","unstructured":"Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ et al (2005) Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine 84:269\u2013276. https:\/\/doi.org\/10.1097\/01.md.0000180042.42156.d1","journal-title":"Medicine"},{"key":"5803_CR53","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1007\/s10067-016-3221-1","volume":"35","author":"C Grossman","year":"2016","unstructured":"Grossman C, Barshack I, Koren-Morag N et al (2016) Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy. Clin Rheumatol 35:1817\u20131822. https:\/\/doi.org\/10.1007\/s10067-016-3221-1","journal-title":"Clin Rheumatol"},{"key":"5803_CR54","first-page":"2624","volume":"27","author":"G Haugeberg","year":"2000","unstructured":"Haugeberg G (2000) Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol 27:2624\u20132627","journal-title":"J Rheumatol"},{"key":"5803_CR55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1754-4505.1998.tb00905.x","volume":"18","author":"SS Hayreh","year":"1998","unstructured":"Hayreh SS (1998) Masticatory muscle pain: an important indicator of giant cell arteritis. Spec Care Dentist 18:60\u201365. https:\/\/doi.org\/10.1111\/j.1754-4505.1998.tb00905.x","journal-title":"Spec Care Dentist"},{"key":"5803_CR56","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.2169\/internalmedicine.50.5205","volume":"50","author":"N Imai","year":"2011","unstructured":"Imai N, Kuroda R, Konishi T et al (2011) Giant cell arteritis: clinical features of patients visiting a headache clinic in Japan. Intern Med 50:1679\u20131682. https:\/\/doi.org\/10.2169\/internalmedicine.50.5205","journal-title":"Intern Med"},{"key":"5803_CR57","doi-asserted-by":"publisher","first-page":"69","DOI":"10.55730\/1300-0144.5767","volume":"54","author":"B \u0130nce","year":"2024","unstructured":"\u0130nce B, I\u015fik EG, \u00d6zkan ZG et al (2024) Evaluation of baseline F-18 FDG positron emission tomography in the diagnosis and assessment of giant cell arteritis. Turk J Med Sci 54:69\u201375. https:\/\/doi.org\/10.55730\/1300-0144.5767","journal-title":"Turk J Med Sci"},{"key":"5803_CR58","doi-asserted-by":"publisher","unstructured":"Jakobsson K, Jacobsson L, Mohammad AJ et al (2016) The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis. BMC Musculoskelet Disord 17. https:\/\/doi.org\/10.1186\/s12891-016-1225-2","DOI":"10.1186\/s12891-016-1225-2"},{"key":"5803_CR59","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1136\/annrheumdis-2012-202408","volume":"72","author":"TA Kermani","year":"2013","unstructured":"Kermani TA, Warrington KJ, Crowson CS et al (2013) Large-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosis. Ann Rheum Dis 72:1989\u20131994. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202408","journal-title":"Ann Rheum Dis"},{"key":"5803_CR60","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3899\/jrheum.141347","volume":"42","author":"TA Kermani","year":"2015","unstructured":"Kermani TA, Warrington KJ, Cuthbertson D et al (2015) Disease relapses among patients with giant cell arteritis: a prospective, longitudinal cohort study. J Rheumatol 42:1213\u20131217. https:\/\/doi.org\/10.3899\/jrheum.141347","journal-title":"J Rheumatol"},{"key":"5803_CR61","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.semarthrit.2011.10.005","volume":"41","author":"TA Kermani","year":"2012","unstructured":"Kermani TA, Schmidt J, Crowson CS et al (2012) Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41:866\u2013871. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.10.005","journal-title":"Semin Arthritis Rheum"},{"key":"5803_CR62","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ejim.2008.07.030","volume":"20","author":"M Khalifa","year":"2009","unstructured":"Khalifa M, Karmani M, Jaafoura NG et al (2009) Epidemiological and clinical features of giant cell arteritis in Tunisia. Eur J Intern Med 20:208\u2013212. https:\/\/doi.org\/10.1016\/j.ejim.2008.07.030","journal-title":"Eur J Intern Med"},{"key":"5803_CR63","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00296-023-05299-1","volume":"43","author":"E Liozon","year":"2023","unstructured":"Liozon E, Parreau S, Dumonteil S et al (2023) New-onset giant cell arteritis with lower ESR and CRP level carries a similar ischemic risk to other forms of the disease but has an excellent late prognosis: a case\u2013control study. Rheumatol Int 43:1323\u20131331. https:\/\/doi.org\/10.1007\/s00296-023-05299-1","journal-title":"Rheumatol Int"},{"key":"5803_CR64","unstructured":"Liozon E, Boutros-Toni F, Ly K et al (2003) Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course. J Rheumatol; 30"},{"key":"5803_CR65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.4321\/s0212-71992004001000002","volume":"21","author":"E Bustamante Maldonado","year":"2004","unstructured":"Bustamante Maldonado E, Mar\u00ed Alfonso B, Monteagudo Jim\u00e9nez M et al (2004) [Analysis of a series of 55 patients with biopsy proven giant cell temporal arteritis]. Med Interna 21:473\u2013476. https:\/\/doi.org\/10.4321\/s0212-71992004001000002","journal-title":"Med Interna"},{"key":"5803_CR66","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ejim.2009.05.002","volume":"20","author":"B Mar\u00ed","year":"2009","unstructured":"Mar\u00ed B, Monteagudo M, Bustamante E et al (2009) Analysis of temporal artery biopsies in an 18-year period at a community hospital. Eur J Intern Med 20:533\u2013536. https:\/\/doi.org\/10.1016\/j.ejim.2009.05.002","journal-title":"Eur J Intern Med"},{"key":"5803_CR67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/md.0b013e31821c4fad","volume":"90","author":"L Martinez-Lado","year":"2011","unstructured":"Martinez-Lado L, Calvi\u00f1o-D\u00edaz C, Pi\u00f1eiro A et al (2011) Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain. Medicine 90:186\u2013193. https:\/\/doi.org\/10.1097\/md.0b013e31821c4fad","journal-title":"Medicine"},{"key":"5803_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0972-2327.93272","volume":"15","author":"T Mathew","year":"2012","unstructured":"Mathew T, Aroor S, Devasia AJ et al (2012) Temporal arteritis: a case series from south India and an update of the Indian scenario. Ann Indian Acad Neurol 15:27\u201330. https:\/\/doi.org\/10.4103\/0972-2327.93272","journal-title":"Ann Indian Acad Neurol"},{"key":"5803_CR69","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/annrheumdis-2019-216145","volume":"79","author":"D Michailidou","year":"2020","unstructured":"Michailidou D, Rosenblum JS, Rimland CA et al (2020) Clinical symptoms and associated vascular imaging findings in Takayasu\u2019s arteritis compared to giant cell arteritis. Ann Rheum Dis 79:262\u2013267. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216145","journal-title":"Ann Rheum Dis"},{"key":"5803_CR70","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/bf02229646","volume":"15","author":"G Nesher","year":"1996","unstructured":"Nesher G, Rubinow A, Sonnenblick M (1996) Trends in the clinical presentation of temporal arteritis in Israel: reflection of increased physician awareness. Clin Rheumatol 15:483\u2013485. https:\/\/doi.org\/10.1007\/bf02229646","journal-title":"Clin Rheumatol"},{"key":"5803_CR71","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/art.20171","volume":"50","author":"G Nesher","year":"2004","unstructured":"Nesher G, Berkun Y, Mates M et al (2004) Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50:1332\u20131337. https:\/\/doi.org\/10.1002\/art.20171","journal-title":"Arthritis Rheum"},{"key":"5803_CR72","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/art.11353","volume":"48","author":"DM Nuenninghoff","year":"2003","unstructured":"Nuenninghoff DM, Hunder GG, Christianson TJH et al (2003) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and\/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48:3522\u20133531. https:\/\/doi.org\/10.1002\/art.11353","journal-title":"Arthritis Rheum"},{"key":"5803_CR73","doi-asserted-by":"publisher","first-page":"917","DOI":"10.55730\/1300-0144.5391","volume":"52","author":"M \u00d6zta\u015f","year":"2022","unstructured":"\u00d6zta\u015f M, \u00d6zg\u00fcl H, Seyahi E et al (2022) Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center. Turk J Med Sci 52:917\u2013925. https:\/\/doi.org\/10.55730\/1300-0144.5391","journal-title":"Turk J Med Sci"},{"key":"5803_CR74","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.01.009","volume":"99","author":"A Pariente","year":"2019","unstructured":"Pariente A, Gu\u00e9don A, Alamowitch S et al (2019) Ischemic stroke in giant-cell arteritis: French retrospective study. J Autoimmun 99:48\u201351. https:\/\/doi.org\/10.1016\/j.jaut.2019.01.009","journal-title":"J Autoimmun"},{"key":"5803_CR75","doi-asserted-by":"publisher","unstructured":"Penet T, Lambert M, Baillet C et al (2023) Giant cell arteritis-related cerebrovascular ischemic events: a French retrospective study of 271 patients, systematic review of the literature and meta-analysis. Arthritis Res Ther 25. https:\/\/doi.org\/10.1186\/s13075-023-03091-x","DOI":"10.1186\/s13075-023-03091-x"},{"key":"5803_CR76","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1097\/rhu.0000000000001942","volume":"29","author":"Q De Gomes","year":"2023","unstructured":"De Gomes Q, Daumas A, Benyamine A et al (2023) Predictors of relapses or recurrences in patients with Giant Cell Arteritis: A Medical Records Review study. J Clin Rheumatol 29:E25\u2013E31. https:\/\/doi.org\/10.1097\/rhu.0000000000001942","journal-title":"J Clin Rheumatol"},{"key":"5803_CR77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/rheumatology\/kem322","volume":"47","author":"WA Schmidt","year":"2008","unstructured":"Schmidt WA, Seifert A, Gromnica-ihle E et al (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 47:96\u2013101. https:\/\/doi.org\/10.1093\/rheumatology\/kem322","journal-title":"Rheumatology (Oxford)"},{"key":"5803_CR78","doi-asserted-by":"publisher","unstructured":"Shimohama S, Imai N, Tsubata T et al (2024) Headache-related characteristics of biopsy-confirmed giant cell arteritis and the relationship of transmural inflammation with artery tenderness and Chordal Thickening. Cureus 16. https:\/\/doi.org\/10.7759\/cureus.56843","DOI":"10.7759\/cureus.56843"},{"key":"5803_CR79","first-page":"372","volume":"58","author":"S Singh","year":"2010","unstructured":"Singh S (2010) Giant cell arteritis in Mumbai. J Assoc Physicians India 58:372\u2013374","journal-title":"J Assoc Physicians India"},{"key":"5803_CR80","doi-asserted-by":"publisher","unstructured":"Skaug HK, Fevang BT, Assmus J et al (2023) Giant cell arteritis: incidence and phenotypic distribution in Western Norway 2013\u20132020. Front Med (Lausanne); 10. https:\/\/doi.org\/10.3389\/fmed.2023.1296393","DOI":"10.3389\/fmed.2023.1296393"},{"key":"5803_CR81","doi-asserted-by":"publisher","first-page":"317","DOI":"10.6061\/clinics\/2013(03)oa06","volume":"68","author":"AWS de Souza","year":"2013","unstructured":"de Souza AWS, Kajiyama Okamoto KY, Abrantes F et al (2013) Giant cell arteritis: a multicenter observational study in Brazil. Clin (Sao Paulo) 68:317\u2013322. https:\/\/doi.org\/10.6061\/clinics\/2013(03)oa06","journal-title":"Clin (Sao Paulo)"},{"key":"5803_CR82","doi-asserted-by":"publisher","unstructured":"Sun F, Ma S, Zheng W et al (2016) A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA): Clinical Features and Factors Associated With Severe Ischemic Manifestations. Medicine; 95: e3213. https:\/\/doi.org\/10.1097\/md.0000000000003213","DOI":"10.1097\/md.0000000000003213"},{"key":"5803_CR83","doi-asserted-by":"publisher","unstructured":"Tuckwell K, Collinson N, Dimonaco S et al 92017) newly diagnosed vs. relapsing giant cell arteritis: baseline data from the GiACTA trial. Semin Arthritis Rheum; 46: 657\u2013664. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.11.002","DOI":"10.1016\/j.semarthrit.2016.11.002"},{"key":"5803_CR84","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1590\/1806-9282.63.11.953","volume":"63","author":"V Yuksel","year":"2017","unstructured":"Yuksel V, Guclu O, Tastekin E et al (2017) Clinical correlation of biopsy results in patients with temporal arteritis. Rev Assoc Med Bras (1992) 63:953\u2013956. https:\/\/doi.org\/10.1590\/1806-9282.63.11.953","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"5803_CR85","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1053\/sarh.2001.16650","volume":"30","author":"MA Gonzalez-Gay","year":"2001","unstructured":"Gonzalez-Gay MA, Garcia-Porrua C, Llorca J et al (2001) Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 30:249\u2013256. https:\/\/doi.org\/10.1053\/sarh.2001.16650","journal-title":"Semin Arthritis Rheum"},{"key":"5803_CR86","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1016\/s2665-9913(21)00246-0","volume":"3","author":"S Chrysidis","year":"2021","unstructured":"Chrysidis S, D\u00f8hn UM, Terslev L et al (2021) Diagnostic accuracy of vascular ultrasound in patients with suspected giant cell arteritis (EUREKA): a prospective, multicentre, non-interventional, cohort study. Lancet Rheumatol 3:e865\u2013e873. https:\/\/doi.org\/10.1016\/s2665-9913(21)00246-0","journal-title":"Lancet Rheumatol"},{"key":"5803_CR87","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1093\/rheumatology\/keac478","volume":"62","author":"AC Bull Haaversen","year":"2023","unstructured":"Bull Haaversen AC, Brekke LK, Kermani TA et al (2023) Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis. Rheumatology (Oxford) 62:1887\u20131894. https:\/\/doi.org\/10.1093\/rheumatology\/keac478","journal-title":"Rheumatology (Oxford)"},{"key":"5803_CR88","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/rheumatology\/keab353","volume":"61","author":"F Wiberg","year":"2021","unstructured":"Wiberg F, Naderi N, Mohammad AJ et al (2021) Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes. Rheumatology (Oxford) 61:383\u2013387. https:\/\/doi.org\/10.1093\/rheumatology\/keab353","journal-title":"Rheumatology (Oxford)"},{"key":"5803_CR89","doi-asserted-by":"publisher","unstructured":"Vincenten SC, Mulleners WM (2021) The quest for a headache pattern in giant cell arteritis: a cohort study. Cephalalgia Rep 4. https:\/\/doi.org\/10.1177\/25158163211024134","DOI":"10.1177\/25158163211024134"},{"key":"5803_CR90","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1001\/archopht.1984.01040030721028","volume":"102","author":"AM Roth","year":"1984","unstructured":"Roth AM, Milsow L, Keltner JL (1984) The ultimate diagnoses of patients undergoing temporal artery biopsies. Arch Ophthalmol 102:901\u2013903. https:\/\/doi.org\/10.1001\/archopht.1984.01040030721028","journal-title":"Arch Ophthalmol"},{"key":"5803_CR91","first-page":"597","volume":"46","author":"WA Hauser","year":"1971","unstructured":"Hauser WA (1971) Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc 46:597\u2013602","journal-title":"Mayo Clin Proc"},{"key":"5803_CR92","first-page":"1279","volume":"32","author":"R Taylor-Gjevre","year":"2005","unstructured":"Taylor-Gjevre R, Vo M, Shukla D et al (2005) Temporal artery biopsy for giant cell arteritis. J Rheumatol 32:1279\u20131281","journal-title":"J Rheumatol"},{"key":"5803_CR93","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/j.1755-3768.2012.02505.x","volume":"91","author":"JJ Gonz\u00e1lez-L\u00f5pez","year":"2013","unstructured":"Gonz\u00e1lez-L\u00f5pez JJ, Gonz\u00e1lez-Moraleja J, Burdaspal-Moratilla A et al (2013) Factors associated to temporal artery biopsy result in suspects of giant cell arteritis: a retrospective, multicenter, case-control study. Acta Ophthalmol 91:763\u2013768. https:\/\/doi.org\/10.1111\/j.1755-3768.2012.02505.x","journal-title":"Acta Ophthalmol"},{"key":"5803_CR94","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.joms.2010.02.027","volume":"69","author":"KL Rieck","year":"2011","unstructured":"Rieck KL, Kermani TA, Thomsen KM et al (2011) Evaluation for clinical predictors of positive temporal artery biopsy in giant cell arteritis. J Oral Maxillofac Surg 69:36\u201340. https:\/\/doi.org\/10.1016\/j.joms.2010.02.027","journal-title":"J Oral Maxillofac Surg"},{"key":"5803_CR95","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ophtha.2010.10.002","volume":"118","author":"MD Walvick","year":"2011","unstructured":"Walvick MD, Walvick MP (2011) Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy. Ophthalmology 118:1201\u20131204. https:\/\/doi.org\/10.1016\/j.ophtha.2010.10.002","journal-title":"Ophthalmology"},{"key":"5803_CR96","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1080\/07853890.2022.2130971","volume":"54","author":"W Moudrous","year":"2022","unstructured":"Moudrous W, Visser LH, Yilmaz T et al (2022) A new prediction model for giant cell arteritis in patients with new onset headache and\/or visual loss. Ann Med 54:2770\u20132776. https:\/\/doi.org\/10.1080\/07853890.2022.2130971","journal-title":"Ann Med"},{"key":"5803_CR97","doi-asserted-by":"publisher","unstructured":"Murchison AP, Bilyk JR (2012) Brow ptosis after temporal artery biopsy: incidence and associations. Ophthalmology.119(12):2637-42. https:\/\/doi.org\/10.1016\/j.ophtha.2012.07.020","DOI":"10.1016\/j.ophtha.2012.07.020"},{"key":"5803_CR98","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1055\/s-0032-1312821","volume":"34","author":"M Aschwanden","year":"2013","unstructured":"Aschwanden M, Daikeler T, Kesten F et al (2013) Temporal artery compression sign\u2013a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med 34:47\u201350. https:\/\/doi.org\/10.1055\/s-0032-1312821","journal-title":"Ultraschall Med"},{"key":"5803_CR99","doi-asserted-by":"publisher","first-page":"ii22","DOI":"10.1093\/rheumatology\/kex461","volume":"57","author":"Schmidt","year":"2018","unstructured":"Schmidt WA (2018) Ultrasound in the diagnosis and management of giant cell arteritis. Rheumatology (Oxford) 57:ii22\u2013ii31. https:\/\/doi.org\/10.1093\/rheumatology\/kex461","journal-title":"Rheumatology (Oxford)"},{"key":"5803_CR100","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-319-21416-0_5","volume":"107","author":"G Schwarzer","year":"2015","unstructured":"Schwarzer G, Carpenter JR, R\u00fccker G (2015) Small-study effects in Meta-Analysis. Meta-Analysis R 107:141. https:\/\/doi.org\/10.1007\/978-3-319-21416-0_5","journal-title":"Meta-Analysis R"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05803-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05803-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05803-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T15:23:46Z","timestamp":1742657026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05803-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":100,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["5803"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05803-9","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All of the authors affirm that they have no financial interest in the topic or materials covered in this manuscript, nor do they have any affiliations with or involvement in any organizations or entities that may have such an interest. The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not relevant to this kind of research (meta-analysis and systematic review).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not relevant to this kind of research (meta-analysis and systematic review).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"47"}}